Delivering on Promises: Enhancing Patient Access to (Neo)adjuvant Cancer Treatments
Author(s)
Moderator: Duane Schulthess, BA, MBA, Vital Transformation, Wezembeek Oppem, VBR, Belgium
Speakers: Nadia Harbeck, MD, PhD, Brustzentrum der Universität München (LMU), Munich, BY, Germany; Francis Arickx, ., National Institute for Health and Disability Insurance (RIZIV-INAMI), Brussels, Belgium; Sean Tunis, MD, MSc., Rubix Health, Baltimore, MD, USA; Milayna Subar, MD, Merck & Co., Kenilworth, NJ, USA
This session’s focus will be on remaining unmet medical need in the fight against cancer; on the promises that (neo)adjuvant cancer treatments offer to patients, physicians, and societies; and on ways to overcome the challenges such treatments face in terms of value demonstration and appreciation. Four speakers - scientific leader, payer, regulator, and an industry representative - will offer their perspectives to get a better understanding of the value of early treatment. They will highlight the unmet medical needs and discuss the potential of (neo)adjuvant treatments to improve cancer treatment along the entire continuum of care (screening, treatment, social care). They will also dive-in on the hurdles to broad and rapid access of (neo)adjuvant treatments with a special view towards limitations around delivery, acceptance, matching of scientific evidence in HTA and P&R context. Finally, the discussion will focus on possible solutions for broader and more rapid access to early treatments such as evidence generation during authorization, innovative contracting, and multi-stakeholder collaboration.
Conference/Value in Health Info
2021-05, ISPOR 2021, Montreal, Canada